Pharma & Biotech
Shield Therapeutics encouraged by US interest in iron deficiency treatment
Circassia Pharmaceuticals plots a path to profitability through diagnostics
Tissue Regenix focused on execution after restructuring
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.